Posts by Admin BioAlps

ADR-AC GmbH, Bern launches a laboratory analysis test service for memory T cells against the novel 2019 Coronavirus

Signature of a collaboration agreement to develop next-generation solutions for rapid microbiological detection Plair SA, the Swiss creator, manufacturer, and provider of instruments for real-time bioaerosol monitoring, and MBV AG, the Swiss global leader in viable air sampling, jointly announce on 2 November 2020 the start of a strategic partnership to bring to the market…

Next generation microfluidic devices for applications in molecular diagnostics   The following article is part of BioAlps’ testimonial series and was written by Prof. Sebastian Maerkl, Associate Professor, Laboratory of Biological Network Characterization (LBNC). Our series aims to provide a platform for the different life sciences actors from western Switzerland, who are active in finding…

Cutting-edge microfluidics to study the behaviour of bacterial pathogens under fluctuating environments   The following article is part of BioAlps’ testimonial series and was written by Dr. Vivek Thacker, Scientist at EPFL School of Life Sciences Laboratory of Microbiology and Microtechnology. Our series aims to provide a platform for the different life sciences actors from…

To meet the high demands for immunoglobulin products, CSL Behring is expanding its manufacturing capacities in Bern   The new state-of-the-art manufacturing facility in Bern (Wankdorf) is home to the production of immunoglobulins (Ig), which allow people worldwide with serious and rare diseases to live life to the fullest. A huge investment project in Bern…

The Geneva-based immune-oncology startup contributing to the SARS-CoV-2 vaccine development   The following article is part of BioAlps’ testimonial series and was written by Mrs Ksenija Pavletic, Board Member at MaxiVAX. Our series aims to provide a platform for the different life sciences actors from western Switzerland, who are active in finding and developing solutions…

Supporting the Company’s Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine   SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today the closing of a $110 million financing round to enter into the next stage of its expansion, with a focus on supporting the growing clinical and biopharma demand for Data-Driven…

A rapid diagnostic test for the detection of antibodies against COVID-19   The following article is part of BioAlps’ testimonial series and was written by Mr Percevent Ducrest, CEO at GaDia. Our series aims to provide a platform for the different life sciences actors from western Switzerland, who are active in finding and developing solutions…

A device capable of autonomously screening the body temperature to detect fever symptoms caused by viral or bacterial infections   The following article is part of BioAlps’ testimonial series and was written by Mr Adrian Shajkofci, Founder of Coronasense. Our series aims to provide a platform for the different life sciences actors from western Switzerland,…